A
ARS Pharmaceuticals, Inc. (SPRY)
NGM – Real vaqt narxi. Valyuta: USD
5.99
+0.04 (0.59%)
Bozor ochiq: Aug 12, 2026, 1:19 PM EDT
5.95
0.00 (0.00%)
Oldingi bozordan keyin: Aug 11, 2026, 7:34 PM EDT
Find any stock by ticker or company name

NGM – Real vaqt narxi. Valyuta: USD
5.99
+0.04 (0.59%)
Bozor ochiq: Aug 12, 2026, 1:19 PM EDT
5.95
0.00 (0.00%)
Oldingi bozordan keyin: Aug 11, 2026, 7:34 PM EDT
This stock has a consensus price target of $28.50 based on the ratings of 7 analysts. The high is $40.00 and the low is $19.00.
| Maqsad | Min. maqsadli narx | O‘rtacha maqsadli narx | Maks. maqsadli narx |
|---|---|---|---|
| Narx | $ 19 | $ 28.5 | $ 40 |
| O’zgarish | 224.23% | 386.35% | 582.59% |
| Sana | O‘sish/pasayish potensiali | Tahlilchi firmasi | Maqsadli narx | Reyting o‘zgarishi | Reyting |
|---|---|---|---|---|---|
| 2026-06-25 | 302.68% | Leerink Partners | $25 → $24 | Maintains | Outperform |
| 2026-05-28 | 403.36% | Cantor Fitzgerald | $12 → $30 | Maintains | Overweight |
| 2025-09-04 | 571.14% | Roth Capital | $40 | Initiates Coverage On | Buy |
| 2025-03-07 | 403.36% | Scotiabank | $30 | Initiates Coverage On | Sector Outperform |
| 2025-01-14 | 369.8% | Raymond James | $26 → $28 | Maintains | Strong Buy |